论文部分内容阅读
目的:探究分析对慢性阻塞性肺疾病(AECOPD)患者采用雾化吸入布地奈德进行治疗的临床效果。方法:选取我院门诊2012年8月~2013年8月接收治疗的63例AECOPD患者作为临床研究对象,按照住院尾号的偶数将其分为32例研究组和31例对照组,对照组患者采取常规治疗,研究组患者在对照组患者治疗的基础上给予雾化吸入布地奈德治疗。结果:治疗后,观察组患者的FEV1改善情况明显优于对照组(P<0.05);观察组患者的治疗总有效率显著高于对照组(P<0.05);观察组患者的喘息缓解时间、咳嗽减轻时间、湿啰音消失时间以及干啰音消失时间明显短于对照组(P<0.05)。结论:对AECOPD患者采取雾化吸入布地奈德进行治疗,能够显著缩短患者的症状、体征消失时间,提高治疗有效率,值得临床推广。
Objective: To investigate the clinical effects of budesonide inhalation for chronic obstructive pulmonary disease (AECOPD). Methods: Sixty-three AECOPD patients receiving treatment from August 2012 to August 2013 in our hospital were selected as clinical research subjects and divided into 32 study groups and 31 control groups according to the even number of hospitalization tail number. The control group Routine treatment was used and patients in the study group were treated with inhaled budesonide based on the treatment of patients in the control group. Results: After treatment, the improvement of FEV1 in observation group was significantly better than that in control group (P <0.05). The total effective rate of observation group was significantly higher than that of control group (P <0.05) Cough relief time, wet rales disappear time and dry rales disappeared significantly shorter than the control group (P <0.05). Conclusion: The treatment of AECOPD with inhaled budesonide can shorten the patient’s symptoms, disappearance of signs and improve the treatment efficiency, worthy of clinical promotion.